FdaApplication
NDA 202171
Identifiers
- fda_app_no: NDA202171
Properties
| Property | Value |
|---|---|
| applicant_name | MATRIX LABS LTD |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE | LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE | 300MG;300MG;200MG | TABLET;ORAL |
1 product